Publikationen von Mira Dalal

Kluge, M.; Schacht, A.; Himmerich, H.; Rummel-Kluge, C.; Wehmeier, P. M.; Dalal, M.; Hinze-Selch, D.; Kraus, T.; Dittmann, R.; Pollmächer, T. et al.; Schuld, A.: Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. SCHIZOPHRENIA RESEARCH 152 (1), S. 255 - 260 (2014)

Kluge, M.; Himmerich, H.; Wehmeier, P. M.; Rummel-Kluge, C.; Dalal, M.; Hinze-Selch, D.; Kraus, T.; Dittmann, R. W.; Pollmächer, T.; Schuld, A.: Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research 135 (1-3), S. 123 - 127 (2012)

Beitinger, P. A.; Fulda, S.; Dalal, M. A.; Wehrle, R.; Keckeis, M.; Wetter, T. C.; Han, F.; Pollmächer, T.; Schuld, A.: Glucose Tolerance in Patients with Narcolepsy. Sleep 35 (2), S. 231 - 236 (2012)

Kluge, M.; Schuld, A.; Schacht, A.; Himmerich, H.; Dalal, M. A.; Wehmeier, P. M.; Hinze-Selch, D.; Kraus, T.; Dittmann, R. W.; Pollmächer, T.: Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 34 (1), S. 118 - 128 (2009)

Dalal, M. A.: What does paroxetine do with sleep? Its effects in mdr 1a/1b (-/-) and fvb wild-type mice. Journal of Sleep Research 17 (Suppl. 1), S. 201 - 201 (2008)

Kluge, M.; Schuld, A.; Himmerich, H.; Dalal, M.; Schacht, A.; Wehmeier, P. M.; Hinze-Selch, D.; Kraus, T.; Dittmann, R. W.; Pollmächer, T.: Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. Journal of Clinical Psychopharmacology 27 (6), S. 662 - 666 (2007)

Wehrle, R.; Beitinger, P.; Dalal, M.; Schuld, A.; Wetter, T. C.; Pollmacher, T.: Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry 40 (5), S. 241 - 241 (2007)

Himmerich, H.; Nickel, T.; Dalal, M. A.; Müller, M. B.: Gabapentin bei einer Patientin mit Panikstörung und Unverträglichkeit von Carbamazepin während des Benzodiazepinentzugs. Psychiatrische Praxis 34 (2), S. 93 - 94 (2007)

Pollmächer, T.; Dalal, M. A.; Schuld, A.: Immunoendocrine abnormalities in narcolepsy. Sleep Medicine Clinics 2, S. 293 - 302 (2007)

Schuld, A.; Birkmann, S.; Beitinger, P.; Haack, M.; Kraus, T.; Dalal, M. A.; Holsboer, F.; Pollmächer, T.: Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation. Experimental and Clinical Endocrinology & Diabetes 114, S. 322 - 328 (2006)

Beitinger, P. A.; Dalal, M. A.; Wehrle, R.; Fulda, S.; Schuld, A.; Wetter, T. C.; Pollmächer, T.: Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 38 (5), S. 230 - 230 (2005)

Dzaja, A.; Dalal, M. A.; Himmerich, H.; Uhr, M.; Pollmächer, T.; Schuld, A.: Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. American Journal of Physiology-Endocrinology and Metabolism 286 (6), S. E963 - E967 (2004)

Dalal, M. A.; Schuld, A.; Pollmächer, T.: Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry 36 (5), S. 218 - 218 (2003)

Schuld, A.; Hinze-Selch, D.; Haack, M.; Dalal, M. A.; Himmerich, H.; Lancel, M.; Pollmächer, T.: Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study. Pharmacopsychiatry 36 (5), S. 263 - 264 (2003)

Dalal, M. A.; Schuld, A.; Pollmächer, T.: Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Molecular Psychiatry 8, S. 836 - 837 (2003)

Dalal, M.; Schuld, A.; Pollmächer, T.: Undetectable CSF level of orexin A (hypocretin-1) in a HLA-DR2 negative patient with narcolepsy-cataplexy. Journal of Sleep Research 11 (3), S. 273 - 273 (2002)

Dalal, M. A.; Schuld, A.; Haack, M.; Uhr, M.; Geisler, P.; Eisensehr, I.; Noachtar, S.; Pollmächer, T.: Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 56, S. 1749 - 1751 (2001)

Kraus, T.; Schuld, A.; Haack, M.; Dalal, M.; Pollmächer, T.: Leptin and psychopharmacology. In: Psychoneuroimmunology. Hypotheses and Current Research. Advances in Biological Psychiatry, Vol. 20, S. 20 - 29 (Hg. Sperner-Unterweger, B.; Fleischhacker, W.; Kaschka, W.). Karger, Basel (2001)